BOSTON — Of the surviving high-surgical-risk patients who underwent transapical transcatheter mitral valve replacement (TMVR) to treat severe mitral regurgitation (MR) at 3 years, echocardiographic outcomes showed stable valve function, persistent MR reduction and a significant reduction in left ventricular end-diastolic volume from baseline, new study results show.